Topical and intravenous administration of human umbilical cord mesenchymal stem cells in patients with diabetic foot ulcer and peripheral arterial disease: a phase I pilot study with a 3-year follow-up

Che Zhang,Li Huang,Xiaofen Wang,Xiaoya Zhou,Xiaoxian Zhang,Ling Li,Jieying Wu,Meng Kou,Cheguo Cai,Qizhou Lian,Xihui Zhou
DOI: https://doi.org/10.1186/s13287-022-03143-0
2022-09-06
Abstract:Diabetic foot ulcer (DFU) is a serious chronic complication of diabetes mellitus that contributes to 85% of nontraumatic lower extremity amputations in diabetic patients. Preliminary clinical benefits have been shown in treatments based on mesenchymal stem cells for patients with DFU or peripheral arterial disease (PAD). However, the long-term safety and benefits are unclear for patients with both DFU and PAD who are not amenable to surgical revascularization.
cell biology,medicine, research & experimental,cell & tissue engineering
What problem does this paper attempt to address?